Last edition
News about "Ichnos Glenmark Innovation"
Ichnos Glenmark Innovation Unveils Novel Multispecific Antibody Candidate for Solid Tumour Treatment
Ichnos Glenmark Innovation has introduced ISB 2301, a next-generation multispecific antibody designed to activate immune cells and target solid tumours through a multi-mechanism approach aimed at improving cancer treatment outcomes.
Ichnos Glenmark Innovation | 22/05/2026 | By News Bureau | 129
Glenmark's IGI Signs Licensing Deal with AbbVie for Investigational Cancer Therapy
AbbVie to lead global development, manufacturing and commercialisation of Ichnos Glenmark Innovation’s (IGI) investigational cancer therapy ISB 2001 in North America, Europe, Japan, and Greater China, while Glenmark will take these roles in emerging markets.
Ichnos Glenmark Innovation | 11/07/2025 | By Dineshwori | 299
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy